Impact of immunohistological subtypes on the long-term prognosis of patients with metastatic breast cancer - Kobayashi, Kokoro; Ito, Yoshinori; Matsuura, Masaaki; Fukada, Ippei; Horii, Rie; Takahashi, Shunji; Akiyama, Futoshi; Iwase, Takuji; Hozumi, Yasuo; Yasuda, Yoshikazu; Hatake, Kiyohiko (Surgery today (Tokyo, Japan), 2016)
Keywords: Antineoplastic Combined Chemotherapy Protocols - therapeutic use; Aromatase Inhibitors - administration & dosage; Breast Neoplasms - diagnosis; Breast Neoplasms - drug therapy; Breast Neoplasms - metabolism; Breast Neoplasms - secondary; Female; Follow-Up Studies; Humans; Immunohistochemistry; Medicine; Medicine & Public Health; Middle Aged; Original Article; Prognosis; Receptor, ErbB-2 - analysis; Retrospective Studies; Surgery; Surgical Oncology; Survival Rate; Time Factors; Trastuzumab - administration & dosage; Intrinsic subtype; Metastatic breast cancer; HER2; Luminal; Triple negative